A European AI factory is being built at Forschungszentrum Jülich. The ExaFlops supercomputer JUPITER is getting a third ...

We also received $30 million in development milestone payments from Bavarian Nordic ... forecasting MCM product sales of $435 million to $485 million across US government and international ...

We also received $30 million in development milestone payments from Bavarian Nordic ... forecasting MCM product sales of $435 million to $485 million across U.S. government and international ...

The Bavarian manufacturer has just announced that production of ... This version increases the combined output by 30 kW to 485 kW and offers a maximum torque of 1.100 Nm. With Launch Control, ...

Looking ahead to the rest of the year, Bavarian Nordic aims to grow earnings some 26% to 30% over that same span. As for what could be next in the company’s travel health portfolio, Bavarian ...

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. The Danish company’s chikungunya vaccine, Vimkunya, has now crossed the FDA finish line, heating up the ...

On track for launch in key European markets in the first half of 2025. COPENHAGEN, Denmark, February 28, 2025 - Bavarian Nordic A/S (OMX: BAVA) today announced that the European Commission has granted ...

First chikungunya vaccine approved for persons as young as 12 years old, addressing an unmet need for chikungunya prevention for younger travelers. On track for commercial launch in the U.S. in ...

We discuss Beijing’s response as Donald Trump’s long-promised tariffs on China, Canada and Mexico come into effect. Then: ...

Good day, and thank you for standing by. Welcome to Emergent BioSolutions Inc. fourth quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After the ...